Your session is about to expire
← Back to Search
Cariprazine for Adolescent Schizophrenia
Study Summary
This trial will test whether cariprazine is an effective and safe treatment for adolescents with schizophrenia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2011 Phase 3 trial • 497 Patients • NCT01058668Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a condition that causes difficulty with learning and problem-solving, and your IQ score is below 70.You have a moderate level of illness according to the CGI-S scale at both the screening and baseline visits.I have been diagnosed with a specific psychotic or bipolar disorder.I have been diagnosed with schizophrenia.My PANSS score is 70 or more with moderate symptoms in at least 2 areas.My schizophrenia diagnosis was confirmed by a clinician using the K-SADS-PL.
- Group 1: Cariprazine 1.5 mg/d
- Group 2: Cariprazine 4.5 mg/d
- Group 3: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research team only want elderly volunteers?
"As this trial strictly adheres to its eligibility criteria, only patients aged 13 to 17 years old may enroll."
Is this research project without precedent?
"Currently, there are 8 different ongoing studies for Cariprazine in 58 distinct cities and 12 separate countries. The first trial was completed in 2019 by Allergan. This trial involved 330 people and completed its Phase 3 approvals. In the two years since, 18280 more trials have been conducted."
When was Cariprazine's FDA approval date?
"Cariprazine has undergone Phase 3 clinical trials, which means that there is some evidence of its efficacy and that it has been tested for safety multiple times. Therefore, our team at Power has given it a safety rating of 3."
Can people with the medical condition still sign up for the test?"
"Yes, this trial is currently open for enrollment according to the website clinicaltrials.gov. This study was first advertised on June 6th, 2019 and was updated as recently as February 18th, 2022."
What other research studies have included Cariprazine as a variable?
"There are a total of 8 different clinical trials underway for Cariprazine. Out of these 8, 5 are in Phase 3. Additionally, while some of the trials are taking place in Nis, New york, there are a total of 189 different locations running trials for Cariprazine."
Share this study with friends
Copy Link
Messenger